Dr. Reddy’s Laboratories Ltd announced the launch of the US Food and Drug Administration (FDA) approved fenofibrate tablets USP, a therapeutic equivalent generic version of Tricor (fenofibrate) tablets.
Dr. Reddy’s fenofibrate tablets USP are available in 54 mg dose in bottle count size of 90 and 160 mg dose in bottle count sizes of 90 and 500. Tricor is a trademark of AbbVie Inc.
Also read: Natco Pharma gets EIR from USFDA
The Tricor brand and generic had US sales of approximately $90 million MAT for the most recent twelve months ending in January 2020, according to IQVIA Health.